Results 1 to 10 of about 60,858 (147)

Maladaptive somatic gene rescue as predisposition to JAK2 molecular abnormalities? Insights from an Israeli family [PDF]

open access: yesAnnals of Hematology
Eosinophilia associated with PCM1::JAK2 fusion and classic Philadelphia (Ph)-negative myeloproliferative neoplasms (MPN) are both clonal disorders caused by a dysregulation of the JAK2 signaling pathway.
Oscar Borsani   +3 more
doaj   +2 more sources

An in vitro investigation of the apoptosis-inducing activity of corosolic acid in breast cancer cells [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2023
Objective(s): Breast cancer is the most prevalent cancer among females with different molecular subtypes. Corosolic acid is a pentacyclic triterpenoid with anti-cancer properties.
Saade Abdalkareem Jasim   +11 more
doaj   +1 more source

Serum erythropoietin in the evaluation of erythrocytosis: How much does it contribute to the diagnosis of polycythemia vera?

open access: yesJournal of Applied Hematology, 2023
INTRODUCTION: Serum erythropoietin (S. EPO) continues to be a minor diagnostic criterion for discriminating polycythemia vera (PV) from other causes of erythrocytosis.
Ruchi Gupta   +7 more
doaj   +1 more source

Clinicopathologic and Molecular Analysis of Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma: A Case Report and Review of Literature

open access: yesTürk Patoloji Dergisi, 2021
Inflammatory pseudotumor-like follicular/fibroblastic dendritic cell (FDC/FRC) sarcoma is an extremely rare neoplasm of the spleen associated with EBV and characterized by spindle cell morphology, dense mixed chronic inflammatory background, and a broad ...
Bryan MORALES-VARGAS   +2 more
doaj   +1 more source

Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India

open access: yesHematology/Oncology and Stem Cell Therapy, 2022
Objective/Background: Recurrent somatic mutations in the JAK2, calreticulin (CALR), and the MPL genes are described as drivers of BCR-ABL1-negative myeloproliferative neoplasms (MPN) that includes polycythemia vera (PV), essential thrombocytosis (ET ...
Madhavi Maddali   +14 more
doaj   +1 more source

Effect of leptin on the growth and expression of STAT3 in yak mammary epithelial cells [PDF]

open access: yesVeterinary World, 2022
Background and Aim: Leptin (LEP) is an autocrine and paracrine factor produced by the fat pad and acinar epithelial cells of the breast. This study aimed to investigate the effects of LEP on yak mammary epithelial cells (YMECs) and the expression of ...
Baoxia Dong   +6 more
doaj   +1 more source

Overt-stage primary myelofibrosis after COVID-19 infection: a case report [PDF]

open access: yesWorld Cancer Research Journal, 2022
OBJECTIVE: Primary Myelofibrosis (PMF) is an uncommon hematological condition where the bone marrow becomes progressively fibrotic, resulting in anemia, extramedullary hematopoiesis, and splenomegaly.
P. Darmada   +3 more
doaj   +1 more source

JAK2 inhibitors

open access: yesMedicina Clínica (English Edition), 2016
Pharmacological inhibition of the kinase activity of JAK proteins can interfere with the signaling of immunomodulatory cytokines and block the constitutive activation of the JAK-STAT pathway that characterizes certain malignancies, including chronic myeloproliferative neoplasms.
Juan Carlos, Hernández Boluda   +2 more
openaire   +5 more sources

Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis

open access: yesCase Reports in Oncology, 2019
Myelofibrosis (MF) can occur due to a wide variety of causes including malignant lymphoma. We report a case of splenic marginal zone lymphoma complicated by MF mimicking primary myelofibrosis (PMF).
Miyuki Tsutsui   +3 more
doaj   +1 more source

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib

open access: yesDrugs in Context, 2020
The Janus kinases (JAK) are a group of molecules, composed of JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2), which are key components within the JAK–signal transducers and activators of transcription pathway, where cytokine receptor signaling takes ...
Novin Nezamololama   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy